Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human Angiopoietin-like Protein 4/ANGPTL4 Antibody, R&D Systems™
Mouse Monoclonal Antibody
Supplier: R&D Systems MAB11305100
This item is not returnable.
View return policy
Description
Angiopoietin-like Protein 4/ANGPTL4 Monoclonal antibody specifically detects Angiopoietin-like Protein 4/ANGPTL4 in Human samples. It is validated for Flow CytometrySpecifications
Angiopoietin-like Protein 4/ANGPTL4 | |
Monoclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. See Certificate of Analysis for details. *Small pack size (-SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS. *Small pack size (SP) is supplied either lyophilized or as a 0.2 μm filtered solution in PBS. | |
angiopoietin-like 4, Angiopoietin-like protein 4, ARP4fasting-induced adipose factor, FIAFhepatic angiopoietin-related protein, Hepatic fibrinogen/angiopoietin-related protein, HFARPANGPTL2, NL2, peroxisome proliferator-activated receptor (PPAR) gamma inducedangiopoietin-related protein, PGARangiopoietin-related protein 4, pp1158, PPARG angiopoietin related protein | |
Mouse myeloma cell line, NS0-derived human Angiopoietin-like Protein 4/ANGPTL4 protein, Gly26-Ser406, Accession # Q9BY76 | |
100 μg | |
Primary | |
Reconstitute at 0.5 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 6 months, -20°C to -70°C under sterile conditions after reconstitution. | |
IgG2b |
Flow Cytometry | |
944740 | |
0.25 μg/106 cells | |
Q9BY76 | |
Mouse | |
Protein A or G purified | |
RUO | |
51129 | |
Human | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction